Bibliografía

Textos consultados

• Real Academia Española: Diccionario de la lengua española, vigésima primera edición. Editorial Espasa Calpe Sociedad Anónima (S.A.) 1992.
• Diccionario terminológico de ciencias médicas, 12ª edición. Salvat Editores (eds.), S.A. 1984.
• Harrison: Principios de Medicina Interna, 14ª Edición. McGraw-Hill Interamericana de España 1998.
• Farreras-Rozman: Medicina Interna, 14ª Edición. Ediciones Harcourt S.A. 2000.
• Catálogo de Especialidades Farmacéuticas. Consejo General de Colegios Oficiales de Farmacéuticos de España, Madrid 2003.
• Vademécum Internacional Medicom. Medimedia-Medicom, S.A. Madrid 2003.
• Alberca Serrano R. et altere (et al). Demencias: diagnóstico y tratamiento. Masson S.A., Barcelona 1998.
• Martínez Lage JM, Martínez-Lage Álvarez P. Concepto, criterios diagnósticos y visión general de las demencias. En: Manual de demencias. López-Pousa S, Villalta J, Llinás J (eds.). Prous Science, Barcelona 1996.
• Martínez Lage JM, Láinez Andrés JM. El Alzheimer: teoría y práctica. Aula médica ediciones, Madrid 2000.
• Agüera Ortiz, L.F: Demencia, una aproximación práctica, 1ª edición. Masson, S.A. 1998.
• Young PA, Young PH. Neuroanatomía clínica funcional. Masson - Williams&Wilkins, Barcelona 1997.
• López-Pousa S, Vilalta Franch J, Llinàs Reglà J (eds.). Manual de Demencias, 2ª Edición. Prous Science, Barcelona 2001.
• Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia: a cause of mental deterioration in the elderly. Lancet 1974;2:207-210.
• Reisberg B, Ferris SH, de León MJ, Crook T. The global deterioration scale for assessment of primary degenerative dementia. American Journal of Psychiatry 1982;139:1136-1139.
• Pfeiffer, E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. Journal of the American Geriatric Society 1975;23:433-441.

Ir al comienzo

• M. B. Graeber, S. Kösel, E. Grasbon-Frodl, H. J. Möller, P. Mehraein. Histopathology and APOE (Apolipoprotein E) genotype of the first Alzheimer disease patient, Auguste D. Neurogenetics 1998;1:223-228.
• Masters CL, Harris JO, Gajdusek DC, et al. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Annals of Neurology 1979;5:177-188.
• McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
• Maurer K, et al. Auguste D and Alzheimer's disease. Lancet 1997;349:1546-1549.
• Bobes J. et al. Instrumentos básicos para la práctica de la psiquiatría clínica. Novartis Farmacéutica, S.A. 2000.
• Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
• Bennett DA, Wilson RS, Gilley DW, Fox JH. Clinical diagnosis of Binswanger's disease. Journal of Neurology, Neurosurgery and Psychiatry 1990;53:961-5.
• R.C. Petersen et al. Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommitee of the American Academy of neurology. Neurology 2001;56:1133-1142.
• D.S. Knopman et al. Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommitee of the American Academy of Neurology. Neurology 2001;56:1143-1153.
• R.S. Doody et al. Practice parameter: Management of dementia (an evidence-based review). Report of the Quality Standards Subcommitee of the American Academy of Neurology. Neurology 2001;56:1154-1166.
• Bas A. int Veld, M.D., Ph.D., Annemieke Ruitenberg, M.D., Ph.D., Albert Hofman, M.D., Ph.D. et al. Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease. New England Journal of Medicine 2001;345:1515-1521.
• Wolozin B, et al. Decreased prevalence of Alzheimer's disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Archives of Neurology. 2000;57:1439-1443.

Ir al comienzo

• Jick H. et al. Statins and the risk of dementia. Lancet 2000;356:1627-1631.
• Timo Erkinjuntti et al. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 2002;359:1283-1290.
• Cummings JL et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopatology in dementia. Neurology 1994;44:2308-14.
• Vilalta-Franch J. et al. Neuropsychiatric Inventory. Propiedades psicométricas de su adaptación al español. Revista de Neurología (España) 1999;29(1):15-19.
• San José Laporte, A. et al. Protocolo de valoración geriátrica. Medicine 1999;7(124):5829-5832.
• Zarit, S.H. et al. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 1980;20:649-655.
• Martín, M. et al. Adaptación para nuestro medio de la escala de sobrecarga del cuidador (Caregiver Burden Interview) de Zarit. Revista de Gerontología (España) 1996;6:338-346.
• Ronald C. Petersen et al. Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology 1999;56:303-308.
• Ronald C. Petersen et al. Current concepts in mild cognitive impairment. Archives of Neurology 2001;58:1985-1992.
• P.W. Duncan et al. Stroke Impact Scale-16: a brief assessment of physical function. Neurology 2003;60:291-296.
• Robinson, B. Validation of a Caregiver Strain Index. Journal of Gerontology 1983;38:344-348.
• Tromp A.M. et al. Fall-risk screening test: a prospective study on predictors for falls in community-dwelling elders. Journal of Clinical Epidemiology 2001;54:837-844.
• Proceedings of the 18th International Conference of Alzheimer's Disease International and the III Conferencia Nacional Alzheimer. Barcelona (Spain) 2002.
• C.A. Luis et al. Mild cognitive impairment: directions for future research. Neurology 2003;61:438-444.
• Claudia H. Kawas. Early Alzheimer's disease. New England Journal of Medicine 2003;349:1056-1063.
• Ruiz M, Rejas J, Soto J, Pardo A, Rebollo I. Adaptación y validación del Health Utilities Index Mark 3 al castellano y baremos de corrección en la población española. Medicina Clínica (Barcelona) 2003;120(3):89-96.
• C. Carnero-Pardo, M.T. Montoro-Ríos. Evaluación preliminar de un nuevo test de cribado de demencia (Eurotest). Revista de Neurología (España) 2004;38:201-209.

Ir al comienzo

• U.P.Mosimann, I. McKeith. Dementia with Lewy bodies: diagnosis and treatment. Swiss Medical Weekly 2003;133:131-142.
• M.A. Lambon Ralph et al. Semantic memory is impaired in both dementia with Lewy bodies and dementia of Alzheimer's type: a comparative neuropsychological study and literature review. Journal of Neurology, Neurosurgery and Psychiatry 2001; 70: 149-156.
• J Calderon et al. Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 2001; 70: 157-164.
• T.J. Ferman et al. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology 2004;62:181-187.
• Debby W. Tsuang et al. Familial occurrence of dementia with Lewy bodies. American Journal of Geriatric Psychiatry 2004;12:179-188.
• McKeith, I. , et al., Dementia with Lewy bodies. Lancet Neurology, 2004. 3: p. 19-28.
• Burn, D.J., et al., Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study. Movement Disorders, 2003. 18(8): p. 884-889.
• Duda, J.E., et al., Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Annals of Neurology, 2002. 52(2): p. 205-210.
• McKeith, I. , et al., Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet, 2000. 356: p. 2031-2036.
• Aarsland D, Mosimann.UP, McKeith IG, Role of Cholinesterase Inhibitors in Parkinson's Disease and dementia with Lewy Bodies. Journal of Geriatric Psychiatry and Neurology, 2004. 17: p. 164-171.
• McKeith, I. , et al., Neuroleptic sensitivity in patients with senile dementia of Lewy body type. British Medical Journal, 1992. 305: p. 673-678.
• Barber, R., A. Panikkar, and I.G. McKeith, Dementia with Lewy bodies: diagnosis and management. International Journal of Geriatric Psychiatry, 2001. 16: p. S12-S18.
• Susan L. Mitchell et al. Estimating prognosis for nursing home residents with advanced dementia. Journal of the American Medical Association 2004;291:2734-2740.
• Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. New England Journal of Medicine 2005;352.
• McKeith IG, Dickson DW, Lowe J, Emre M et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863-1872.
• F Portet, P J Visser, G B Frisoni, J Nobili, Ph Scheltens, B Vellas and J Touchon. Mild cognitive impairment in medical practice: critical review of the concept and new diagnostic procedure. Report of the Mild Cognitive Impairment (MCI) working group of the European Consortium on Alzheimer's Disease (EADC). Journal of Neurology, Neurosurgery and Psychiatry 2006. digital object identifier (doi): 10.1136/jnnp.2005.085332.
• C. Carnero-Pardo, M.T. Montoro-Ríos. Test de las Fotos. Revista de Neurología (España) 2004;39:801-806.
• The American Psychiatric Association. Practice guideline for the treatment of patients with Alzheimer's disease and other dementias, second edition. The American Journal of Psychiatry 2007 (December 2007 supplement).
• Fernández Huerta, José. Medidas sencillas de lecturabilidad. Consigna 1959;214: 29-32.

Ir al comienzo